
Amphastar Pharmaceuticals Inc
NASDAQ:AMPH

Intrinsic Value
The intrinsic value of one
AMPH
stock under the Base Case scenario is
43.54
USD.
Compared to the current market price of 25.71 USD,
Amphastar Pharmaceuticals Inc
is
Undervalued by 41%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Amphastar Pharmaceuticals Inc
Fundamental Analysis


Revenue & Expenses Breakdown
Amphastar Pharmaceuticals Inc
Balance Sheet Decomposition
Amphastar Pharmaceuticals Inc
Current Assets | 588m |
Cash & Short-Term Investments | 236.9m |
Receivables | 145.4m |
Other Current Assets | 205.7m |
Non-Current Assets | 1B |
Long-Term Investments | 5.9m |
PP&E | 353.8m |
Intangibles | 584.5m |
Other Non-Current Assets | 94.1m |
Free Cash Flow Analysis
Amphastar Pharmaceuticals Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Amphastar Pharmaceuticals Inc
Revenue
|
730.7m
USD
|
Cost of Revenue
|
-361.7m
USD
|
Gross Profit
|
369m
USD
|
Operating Expenses
|
-174.3m
USD
|
Operating Income
|
194.7m
USD
|
Other Expenses
|
-53.1m
USD
|
Net Income
|
141.6m
USD
|
AMPH Profitability Score
Profitability Due Diligence
Amphastar Pharmaceuticals Inc's profitability score is 64/100. The higher the profitability score, the more profitable the company is.

Score
Amphastar Pharmaceuticals Inc's profitability score is 64/100. The higher the profitability score, the more profitable the company is.
AMPH Solvency Score
Solvency Due Diligence
Amphastar Pharmaceuticals Inc's solvency score is 52/100. The higher the solvency score, the more solvent the company is.

Score
Amphastar Pharmaceuticals Inc's solvency score is 52/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
AMPH Price Targets Summary
Amphastar Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for
AMPH
is 35.96 USD
with a low forecast of 31.31 USD and a high forecast of 42 USD.
Dividends
Current shareholder yield for AMPH is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
AMPH
stock under the Base Case scenario is
43.54
USD.
Compared to the current market price of 25.71 USD,
Amphastar Pharmaceuticals Inc
is
Undervalued by 41%.